Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex.
Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex.
复制标题
DOI:
10.1038/nn.4181
复制
发表时间:
2016-01
影响因子:
25
通讯作者:
Kleinman JE
中科院分区:
文献类型:
--
作者:
Jaffe AE;Gao Y;Deep-Soboslay A;Tao R;Hyde TM;Weinberger DR;Kleinman JE
DNA methylation (DNAm) is important in brain development, and potentially in schizophrenia. We characterized DNAm in prefrontal cortex from 335 non-psychiatric controls across the lifespan and 191 patients with schizophrenia, and identified widespread changes in the transition from prenatal to postnatal life. These DNAm changes manifest in the transcriptome, correlate strongly with a shifting cellular landscape, and overlap regions of genetic risk for schizophrenia. A quarter of published GWAS-suggestive loci (4,208/15,930, p<10−100) manifest as significant methylation quantitative trait loci (meQTLs), including 59.6% of GWAS-positive schizophrenia loci. We identified 2,104 CpGs that differ between schizophrenia patients and controls, enriched for genes related to development and neurodifferentiation. The schizophrenia-associated CpGs strongly correlate with changes related to the prenatal-postnatal transition and show slight enrichment for GWAS risk loci, while not corresponding to CpGs differentiating adolescence from later adult life. These data implicate an epigenetic component to the developmental origins of this disorder.